Skip to content

Studying the effectiveness of vaginal radiofrequency on ovarian reserve in people with reduced ovarian reserve

: Comparison the effect of ovarian PRP with and without vaginal RF on the number of oocyte and embryos in patients with diminished ovarian reserve and candidates for IVF

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20160722029027N15
Enrollment
60
Registered
2025-08-26
Start date
2025-08-03
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Decreased ovarian reserve.

Interventions

Intervention 1: Intervention group:The intervention group includes people who undergo vaginal RF in addition to ovarian PRP. First, patients enter an IVF cycle with a fixed protocol, and simultaneous

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to 45 Years

Inclusion criteria

Inclusion criteria: Having diminished ovarian reserve as defined by an antral follicle count or AFC of less than 5 to 7 follicles and an AMH level of less than 1.1 ng/ml who presented for infertility. Normal vaginal endocytology without any evidence of malignancy with atypia. Not receiving hormone replacement therapy for six months, no pacemaker or any metal device in the pelvic area.

Exclusion criteria

Exclusion criteria: For any reason, the patient is unwilling to participate in the study.

Design outcomes

Primary

MeasureTime frame
Number of oocyte. Timepoint: Before and after vaginal RF. Method of measurement: Counting with a microscope.;Number of embryo. Timepoint: Before and after vaginal RF. Method of measurement: Counting with a microscope.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactLeila Nazari

Shahid Beheshti University of Medical Sciences

nazari@sbmu.ac.ir+98 912 316 4282

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026